Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2011
CompletedFirst Posted
Study publicly available on registry
October 21, 2011
CompletedOctober 21, 2011
September 1, 2008
October 18, 2011
October 20, 2011
Conditions
Keywords
Study Arms (2)
Control (chemotherapy and surgery)
ACTIVE COMPARATORPatients treated with chemotherapy + surgery
Study
ACTIVE COMPARATORPatients treated only with chemotherapy
Interventions
Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy
Eligibility Criteria
You may qualify if:
- \- patients that did not underwent surgery
You may not qualify if:
- \- patients that underwent surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 18, 2011
First Posted
October 21, 2011
Last Updated
October 21, 2011
Record last verified: 2008-09